The United States Pharmacopeial Convention (USP) has announced three recipients of its 2014–2015 Global Fellowship Awards. One of the recipients of the $30,000 fellowship, Ahmed Shalash of Alexandria University in Alexandria, Egypt, is researching carriers for dry powder inhaler formulations. According to USP, "The research deals with investigation of the role of … [Read more...] about USP awards fellowship for DPI research
People
Formex LLC hires John McCarty as Scientific Advisor
CDMO Formex, LLC has announced that former Azo Pharma VP of Formulation Development John McCarty has joined the company as Scientific Advisor. McCarty will also serve as a member of the company's Science Advisory Board. Formex cites McCarty's "broad expertise in the development of all major dosage forms" and "over 17" patents. Formex Chief Scientific Officer J. … [Read more...] about Formex LLC hires John McCarty as Scientific Advisor
Theravance appoints Michael W. Aguiar President and CEO
Theravance has announced that Michael W. Aguiar will replace Rick E Winningham as President and CEO effective August 15, 2014. Winningham will become CEO of Theravance Biopharma full time and will continue as Chairman of the Board of Directors of Theravance, Inc. Aguiar, who is currently Senior VP and Chief Financial Officer, joined Theravance in 2005 and led the … [Read more...] about Theravance appoints Michael W. Aguiar President and CEO
Milestone Pharmaceuticals appoints Francis Plat as Chief Medical Officer
Canadian pharmaceutical company Milestone Pharmaceuticals, which is developing an intranasal short-acting calcium channel antagonist for the treatment of paroxysmal supraventricular tachycardia, has announced the appointment of Francis Plat as Chief Medical Officer. Dr. Plat commented, "I am highly enthused to join Milestone in its development of MSP-2017, a … [Read more...] about Milestone Pharmaceuticals appoints Francis Plat as Chief Medical Officer
Theravance appoints Theodore J. Witek Senior VP Corporate Partnerships, Clinical and Medical Affairs
Theravance has announced the appointment of Theodore J. Witek, Jr. as Senior VP Corporate Partnerships, Clinical and Medical Affairs. In that capacity, the company says Witek "will be focused on the further development of the respiratory programs partnered with Glaxo Group Limited (GSK)," including the Anoro and Breo/Ellipta DPIs. Witek was most recently President and … [Read more...] about Theravance appoints Theodore J. Witek Senior VP Corporate Partnerships, Clinical and Medical Affairs
Alexza names Edwin S. Kamemoto as Senior VP of Regulatory Affairs
Alexza Pharmaceuticals has promoted Edwin S. Kamemoto from VP, Regulatory Affairs to the newly created position of Senior VP, Regulatory Affairs. He was hired in 2006 as Associate Director, Regulatory Affairs; and promoted to Director, Regulatory Affairs, then to Senior Director, Regulatory Affairs, and then, in 2010, to Executive Director, Regulatory Affairs. … [Read more...] about Alexza names Edwin S. Kamemoto as Senior VP of Regulatory Affairs
Presspart adds two to its Inhalation Product Technology Centre team
Device component company Presspart Manufacturing has announced that former Lupin pulmonary research scientist Abhay Singh and former Sanofi QC readiness analyst Jacqueline Green have joined Presspart's Inhalation Product Technology Centre (IPTC) team. Singh has been hired as Senior Analyst, Green as Research Analyst. In late 2012, Presspart announced that it had … [Read more...] about Presspart adds two to its Inhalation Product Technology Centre team
OptiNose announces senior management additions
OptiNose has announced three hires for senior management positions, which it says "will help drive the company forward in its mission to introduce new and valuable treatment options to the market utilizing its novel Bi-Directional Breath Powered Delivery Technology." The company has hired Ramona Lloyd as VP, Regulatory Affairs & Quality; Sheila Bergey as VP, … [Read more...] about OptiNose announces senior management additions
Parion announces management changes
Parion Sciences, which is developing a trans-nasal aerosol delivery system and several products for cystic fibrosis, has announced several changes to its executive team. Paul Boucher, previously VP of Finance & Business has been promoted to President; Joe Schachle, previously Head of Global Marketing Operations at Grifols, has been hired as Chief Operating Officer; … [Read more...] about Parion announces management changes
Retrophin names new President/COO and Executive VP of R&D
Retrophin, which is developing Syntocinon intranasal oxytocin, has named Stephen Aselage as President and Chief Operations Officer and Alvin Shih as Executive VP of Research and Development. Aselage, who has stepped down as CEO, was Executive VP and Chief Business Officer at BioMarin Pharmaceutical before joining Retrophin in 2012, and Shih is currently COO of … [Read more...] about Retrophin names new President/COO and Executive VP of R&D